Masimo sells a range of devices used for patient monitoring that feature a proprietary pulse oximetry technology called Signal Extraction Technology (SET). In the latest update on that patent spat ...

Masimo Corporation (Nasdaq: MASI) today announced select preliminary financial results for the fourth quarter and full-year ended December 28, 2024 and provided estimates for its full-year 2025 ...

In late 2023, Apple received a small blow to its lucrative Christmas sales period thanks to the medical device manufacturer ...

Masimo Corp. and Apple Inc. have filed dueling post-trial briefs in a California federal court, following a retrial over ...

with Masimo previously accusing Apple of poaching its employees and copying its pulse oximetry technology. Why It Matters: ...

Offers optional dual IBP, and EtCo 2 — Now with Masimo SET ® Pulse Oximetry! The fully-functional Waveline Touch features a 12.1" color TFT display with a touch-screen interface. It features ...

Masimo (NASDAQ: MASI) today announced that its management will participate in the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2025 at 10:30 a.m. Pacific time. A live webcast ...